BlackRock Advisors’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $2.6M | Sell |
282,128
-59,261
| -17% | -$545K | ﹤0.01% | 1348 |
|
|
2016
Q3 | $4.03M | Buy |
341,389
+61,758
| +22% | +$728K | ﹤0.01% | 1149 |
|
|
2016
Q2 | $3.62M | Buy |
279,631
+25,192
| +10% | +$326K | ﹤0.01% | 1204 |
|
|
2016
Q1 | $4.07M | Sell |
254,439
-43,411
| -15% | -$694K | ﹤0.01% | 1149 |
|
|
2015
Q4 | $8.53M | Buy |
297,850
+282,939
| +1,898% | +$8.1M | 0.01% | 895 |
|
|
2015
Q3 | $424K | Buy |
14,911
+124
| +0.8% | +$3.53K | ﹤0.01% | 2270 |
|
|
2015
Q2 | $531K | Buy |
14,787
+3,637
| +33% | +$131K | ﹤0.01% | 2104 |
|
|
2015
Q1 | $324K | Buy |
11,150
+1,414
| +15% | +$41.1K | ﹤0.01% | 2362 |
|
|
2014
Q4 | $205K | Sell |
9,736
-128,118
| -93% | -$2.7M | ﹤0.01% | 2577 |
|
|
2014
Q3 | $2.67M | Sell |
137,854
-661,472
| -83% | -$12.8M | ﹤0.01% | 1077 |
|
|
2014
Q2 | $12.5M | Buy |
799,326
+511,150
| +177% | +$7.98M | 0.01% | 704 |
|
|
2014
Q1 | $5.97M | Sell |
288,176
-670,018
| -70% | -$13.9M | 0.01% | 916 |
|
|
2013
Q4 | $12.4M | Sell |
958,194
-246,987
| -20% | -$3.19M | 0.01% | 708 |
|
|
2013
Q3 | $14.1M | Sell |
1,205,181
-167,037
| -12% | -$1.95M | 0.01% | 663 |
|
|
2013
Q2 | $6.33M | Buy |
+1,372,218
| New | +$6.33M | 0.01% | 894 |
|